CDCA7L
Cell division cycle-associated 7-like protein
Also known as: CDA7L_HUMAN, JPO2, R1, RAM2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96GN5
- Gene
- CDCA7L
- Ensembl
- ENSG00000164649
- Chromosome
- 7
- Canonical length
- 454 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Nucleoli fibrillar center,Cytosol
OverviewNCBI Gene
Acts upstream of or within positive regulation of cell population proliferation. Located in cytosol; fibrillar center; and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
454 residues, UniProt reviewed canonical sequence.
>Q96GN5|CDCA7L
1 MELATRYQIP KEVADIFNAP SDDEEFVGFR DDVPMETLSS EESCDSFDSL ESGKQQDVRF
61 HSKYFTEELR RIFIEDTDSE TEDFAGFTQS DLNGKTNPEV MVVESDLSDD GKASLVSEEE
121 EDEEEDKATP RRSRSRRSSI GLRVAFQFPT KKLANKPDKN SSSEQLFSSA RLQNEKKTIL
181 ERKKDCRQVI QREDSTSESE DDSRDESQES SDALLKRTMN IKENKAMLAQ LLAELNSMPD
241 FFPVRTPTSA SRKKTVRRAF SEGQITRRMN PTRSARPPEK FALENFTVSA AKFAEEFYSF
301 RRRKTIGGKC REYRRRHRIS SFRPVEDITE EDLENVAITV RDKIYDKVLG NTCHQCRQKT
361 IDTKTVCRNQ GCCGVRGQFC GPCLRNRYGE DVRSALLDPD WVCPPCRGIC NCSYCRKRDG
421 RCATGILIHL AKFYGYDNVK EYLESLQKEL VEDNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDCA7L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 49 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 49 nTPM
- thymus: 46 nTPM
- lymph node: 35 nTPM
- tonsil: 30 nTPM
- thyroid gland: 28 nTPM
- heart muscle: 24 nTPM
Single-cell type
- oocytes: 263 nCPM
- neutrophil progenitors: 181 nCPM
- undifferentiated spermatogonia: 82 nCPM
- differentiating spermatogonia: 61 nCPM
- cardiomyocytes: 60 nCPM
- b-cells: 54 nCPM
Immune cell
- naive B-cell: 125 nTPM
- memory B-cell: 101 nTPM
- plasmacytoid DC: 76 nTPM
- eosinophil: 43 nTPM
- naive CD4 T-cell: 31 nTPM
- myeloid DC: 15 nTPM
Brain region
- choroid plexus: 38 nTPM
- white matter: 20 nTPM
- basal ganglia: 19 nTPM
- thalamus: 17 nTPM
- medulla oblongata: 16 nTPM
- cerebellum: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CDCA7L.
Disease | ImmuneIEDB
Conditions an epitope on CDCA7L was assayed in.
- chronic lymphocytic leukemia T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.09
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDCA7L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDCA7L as an antibody target. Whether an autoantibody or antibody against CDCA7L could matter depends on whether native CDCA7L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDCA7L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDCA7L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...